RGN-352 was shown to be safe and well-tolerated with no serious drug-related adverse events reported (PMID: 20536472) Phase 2 AMI trial (incomplete): RegeneRx designed a Phase 2 proof-of-concept trial (NCT01311518) to evaluate RGN-352 in approximately 75 patients with acute ST-segment elevation myocardial infarction (heart attack)
TRIM BODY INJECTION (LIPO MINO) $43.00 VITAMIN INJECTION Fat Burner that helps breakdown fat, reduce appetite, Boost Metabolism, build muscle and promote a healthy immune system
Ipamorelin is preferred partly because it doesn't significantly affect appetite
Cuskelly GJ, Mooney KM, Young IS
Enhances muscle recovery after workouts
IV Solutions and IV Systems Hospira IV solutions include normal saline, dextrose solutions, lactated Ringer's, and specialty electrolyte blends in multiple bag sizes